• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biomarkers for tuberculosis disease activity, cure, and relapse.

作者信息

Phillips Patrick Peter John, Davies Geraint R, Mitchison Denis A

出版信息

Lancet Infect Dis. 2010 Feb;10(2):69-70; author reply 70-1. doi: 10.1016/S1473-3099(09)70256-7.

DOI:10.1016/S1473-3099(09)70256-7
PMID:20113973
Abstract
摘要

相似文献

1
Biomarkers for tuberculosis disease activity, cure, and relapse.
Lancet Infect Dis. 2010 Feb;10(2):69-70; author reply 70-1. doi: 10.1016/S1473-3099(09)70256-7.
2
[Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy].
Bull Int Union Tuberc. 1978 Dec;53(4):276-80.
3
[Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].6至8个月化疗方案治疗肺结核的对照试验。香港胸科服务处/英国医学研究委员会研究]
Bull Int Union Tuberc. 1978 Dec;53(4):253.
4
Extra-pulmonary and pulmonary tuberculosis in Hong Kong.香港的肺外结核和肺结核
Int J Tuberc Lung Dis. 2002 Oct;6(10):879-86.
5
A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.痰涂片阴性肺结核3个月、4个月和6个月化疗方案的对照试验。5年结果。香港胸科服务处/马德拉斯结核病研究中心/英国医学研究委员会
Am Rev Respir Dis. 1989 Apr;139(4):871-6. doi: 10.1164/ajrccm/139.4.871.
6
Preliminary results of the Hong Kong/British Medical Research Council second controlled trial of short-course antituberculosis regimens [proceedings].香港/英国医学研究委员会第二项短程抗结核治疗方案对照试验的初步结果[会议记录]
Tubercle. 1978 Mar;59(1):64. doi: 10.1016/0041-3879(77)90028-9.
7
Chemotherapy in Hong Kong.香港的化疗
Bull Int Union Tuberc. 1972 Aug;47 Suppl 2:52.
8
Biomarkers for tuberculosis disease activity, cure, and relapse.用于结核病疾病活动、治愈和复发的生物标志物。
Lancet Infect Dis. 2010 Feb;10(2):68-9. doi: 10.1016/S1473-3099(10)70003-7.
9
Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.肺结核五种6个月化疗方案对照试验的五年随访。香港胸科服务处/英国医学研究委员会
Am Rev Respir Dis. 1987 Dec;136(6):1339-42. doi: 10.1164/ajrccm/136.6.1339.
10
In the treatment of tuberculosis, you get what you pay for..在结核病治疗中，一分钱一分货。
Am J Respir Crit Care Med. 2004 Nov 15;170(10):1040-2. doi: 10.1164/rccm.2409005.

引用本文的文献

1
Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?吲哚胺 2,3-双加氧酶介导的色氨酸分解代谢：在结核分枝杆菌和 HIV 共舞中是主角还是配角？
Front Cell Infect Microbiol. 2019 Oct 29;9:372. doi: 10.3389/fcimb.2019.00372. eCollection 2019.
2
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.新结核病治疗方案的研发：协调临床试验设计、产品注册要求和公共卫生指南。
PLoS Med. 2019 Sep 6;16(9):e1002915. doi: 10.1371/journal.pmed.1002915. eCollection 2019 Sep.
3
Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis.
耐多药肺结核患者的痰液细菌学转化及治疗结果
Infect Drug Resist. 2018 Jan 23;11:147-154. doi: 10.2147/IDR.S153499. eCollection 2018.
4
Assessment of treatment response in tuberculosis.结核病治疗反应的评估
Expert Rev Respir Med. 2016 Jun;10(6):643-54. doi: 10.1586/17476348.2016.1166960. Epub 2016 Mar 31.
5
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).一种加速结核病药物研发的新试验设计：具有延长治疗后随访期的II期C选择试验（STEP）。
BMC Med. 2016 Mar 23;14:51. doi: 10.1186/s12916-016-0597-3.
6
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials.在个体患者护理决策以及将新方案推进至确证性临床试验方面，培养转化的作用有限。
BMC Med. 2016 Feb 4;14:19. doi: 10.1186/s12916-016-0565-y.
7
Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.基于磁珠分离和质谱分析的痰涂片阳性肺结核血清诊断模式的比较蛋白质组学分析
Int J Clin Exp Med. 2015 Feb 15;8(2):2077-85. eCollection 2015.
8
Monitoring Therapeutic Response in a Case of Extrapulmonary Tuberculosis by Serial F-18 FDG PET/CT.通过连续F-18 FDG PET/CT监测一例肺外结核的治疗反应
Nucl Med Mol Imaging. 2012 Mar;46(1):69-72. doi: 10.1007/s13139-011-0114-8. Epub 2011 Nov 10.
9
Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.筛选和鉴定六种血清 microRNAs 作为新型潜在的肺结核诊断组合生物标志物。
PLoS One. 2013 Dec 5;8(12):e81076. doi: 10.1371/journal.pone.0081076. eCollection 2013.
10
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses.Toll 样受体 4 通路可溶性标志物可区分活动性和潜伏性结核病，并与治疗反应相关。
PLoS One. 2013 Jul 16;8(7):e69896. doi: 10.1371/journal.pone.0069896. Print 2013.